Memorial Sloan Kettering Sloan Kettering 2 is a clinical research site located in New York, New York, United States 10017.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Sloan Kettering 2 has participated in 1 clinical trials.
Therapeutic areas: Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.
Sponsors: Novartis Pharmaceuticals.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Sloan Kettering 2 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Sloan Kettering 2 has 1 clinical trials on record. Their work covers Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, Acute Myeloid Leukemia.
Memorial Sloan Kettering Sloan Kettering 2 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.